1-20 of 98
Authors: E. Antonio Chiocca
Save search
Sort by
Journal Article
ACCEPTED MANUSCRIPT

A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma Get access

PDF
Patrick Y Wen and others
Neuro-Oncology, noaf079, https://doi.org/10.1093/neuonc/noaf079
Published: 22 March 2025
Journal Article

CTIM-28. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT Free

PDF
J Ricardo McFaline-Figueroa and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi.org/10.1093/neuonc/noae165.0361
Published: 11 November 2024
Journal Article

TMIC-58. LEVERAGING VIRO-IMMUNOTHERAPY BY TARGETING IGF2-IGF1R SIGNALING Free

PDF
MinHye Noh and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii311, https://doi.org/10.1093/neuonc/noae165.1236
Published: 11 November 2024
Journal Article

DDDR-37. OHSV AND RADIATION THERAPIES SENSITIZE GLIOBLASTOMA TO IGF1R-TARGETED THERAPY AND SYNERGIZE IN TRIPLE COMBINATION THERAPY Free

PDF
Alexandra A Miller and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii133–viii134, https://doi.org/10.1093/neuonc/noae165.0522
Published: 11 November 2024
Journal Article

Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors Open Access

PDF
Hia S Ghosh and others
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 195–208, https://doi.org/10.1093/neuonc/noae164
Published: 21 August 2024
Journal Article

Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy Open Access

PDF
Min Hye Noh and others
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1602–1616, https://doi.org/10.1093/neuonc/noae105
Published: 10 June 2024
Journal Article
EDITOR'S CHOICE

Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling? Free

PDF
Ethan Chen and others
Neuro-Oncology, Volume 26, Issue 2, February 2024, Pages 211–225, https://doi.org/10.1093/neuonc/noad211
Published: 23 November 2023
Journal Article

MODL-42. BLOOD-BRAIN TUMOR BARRIER ORGANOID MODEL FOR THERAPEUTIC DELIVERY TO GLIOBLASTOMA Free

PDF
Pei Zhuang and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v308, https://doi.org/10.1093/neuonc/noad179.1193
Published: 10 November 2023
Journal Article

EXTH-70. UTILIZING ONCOLYTIC VIROTHERAPY AS AN APPROACH TO ENHANCE NEOANTIGEN SPECIFIC IMMUNE RESPONSES IN GLIOBLASTOMA Free

PDF
Raziye Piranlioglu and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v240, https://doi.org/10.1093/neuonc/noad179.0923
Published: 10 November 2023
Journal Article

PATH-35. SHIFTS IN GLIOMA PROGNOSTIC MOLECULAR FEATURES ACROSS THE LIFESPAN Free

PDF
Ruchit Patel and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v175–v176, https://doi.org/10.1093/neuonc/noad179.0665
Published: 10 November 2023
Journal Article

PATH-12. CONTEMPORARY MOLECULAR LANDSCAPE, SURVIVAL, AND PROGNOSTIC FACTORS IN OVER 4,000 GLIOMAS Free

PDF
Hia Ghosh and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v169, https://doi.org/10.1093/neuonc/noad179.0642
Published: 10 November 2023
Journal Article

BIOM-20. NEAT1 EXPRESSION IS ASSOCIATED WITH GLIOBLASTOMA PATIENT RESPONSE TO IMMUNE CHECKPOINT INHIBITORS Free

PDF
Joseph Toker and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v8, https://doi.org/10.1093/neuonc/noad179.0031
Published: 10 November 2023
Journal Article

CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPIES Free

PDF
Rifaquat Rahman and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v76–v77, https://doi.org/10.1093/neuonc/noad179.0299
Published: 10 November 2023
Journal Article

EPCO-03. A COMPREHENSIVE SINGLE-CELL ATLAS OF SCHWANNOMA REVEALS CONSERVED CELLULAR STATES ACROSS DIFFERENT GENETIC BACKGROUNDS AND ANATOMIC LOCATIONS Free

PDF
Luis Nicolas Gonzalez Castro and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v123–v124, https://doi.org/10.1093/neuonc/noad179.0468
Published: 10 November 2023
Journal Article

CTIM-41. ONCOLYTIC IMMUNOTHERAPY LINKS IMMUNOACTIVATION TO SUBJECT SURVIVAL IN PHASE I TRIAL OF RECURRENT GLIOBLASTOMA Free

PDF
Alexander Ling and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v72, https://doi.org/10.1093/neuonc/noad179.0281
Published: 10 November 2023
Journal Article

Oncolytic immunoactivation associates with survival in a glioblastoma clinical trial Free

PDF
Alexander L Ling and E Antonio Chiocca
Neuro-Oncology, Volume 26, Issue 2, February 2024, Pages 209–210, https://doi.org/10.1093/neuonc/noad216
Published: 06 November 2023
Journal Article

CTIM-25. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT Free

PDF
J Ricardo McFaline-Figueroa and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii65–vii66, https://doi.org/10.1093/neuonc/noac209.257
Published: 14 November 2022
Journal Article

EXTH-54. CO-CULTURE OF PATIENT-DERIVED GLIOBLASTOMA CELL LINES WITH AUTOLOGOUS PBMCS FOR THE INVESTIGATION OF ONCOLYTIC VIRUS RESPONSE Free

PDF
Eftychia Stavrakaki and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii221, https://doi.org/10.1093/neuonc/noac209.852
Published: 14 November 2022
Journal Article

CTNI-11. DEEP PHENOTYPING OF MULTI DRUG RESPONSES IN PATIENTS WITH GLIOMAS USING TUMOR-EMBEDDED MICRODEVICES Free

PDF
Pierpaolo Peruzzi and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii72, https://doi.org/10.1093/neuonc/noac209.277
Published: 14 November 2022
Journal Article

CTIM-09. ENRICHED TCR/BCR VDJ REARRANGEMENTS CORRELATE WITH MRI AND SURVIVAL OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA TREATED WITH CAN-3110 Free

PDF
E Antonio Chiocca and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii61, https://doi.org/10.1093/neuonc/noac209.241
Published: 14 November 2022